Sio Capital Management, LLC Mei Pharma, Inc. Transaction History

Sio Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $230,065 - $1.17 Million	-426,047 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $57,200 - $73,040	-22,000 Reduced 4.91%	426,047 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$2.46 - $4.27 $984,000 - $1.71 Million	400,000 Added 832.52%	448,047 $1.4 Million
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $3.53 Million - $10.5 Million	-2,437,051 Reduced 98.07%	48,047 $198,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $64,684 - $219,927	86,246 Added 3.6%	2,485,098 $4 Million
Q4 2019 Feb 14, 2020	BUY	$1.65 - $2.48 $3.53 Million - $5.31 Million	2,140,000 Added 826.73%	2,398,852 $5.95 Million
Q3 2019 Nov 14, 2019	SELL	$1.48 - $2.52 $1.85 Million - $3.15 Million	-1,251,234 Reduced 82.86%	258,852 $435,000
Q2 2019 Aug 14, 2019	SELL	$2.45 - $3.32 $2.07 Million - $2.81 Million	-846,547 Reduced 35.92%	1,510,086 $3.78 Million
Q1 2019 May 15, 2019	SELL	$2.52 - $3.24 $43,364 - $55,753	-17,208 Reduced 0.72%	2,356,633 $7.24 Million
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $134,776 - $287,803	70,196 Added 3.05%	2,373,841 $6.27 Million
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $405,644 - $551,627	119,659 Added 5.48%	2,303,645 $9.93 Million
Q2 2018 Aug 14, 2018	BUY	$1.89 - $4.95 $2.36 Million - $6.18 Million	1,249,423 Added 133.69%	2,183,986 $8.61 Million
Q1 2018 May 15, 2018	BUY	$2.06 - $2.38 $221,759 - $256,207	107,650 Added 13.02%	934,563 $1.94 Million
Q4 2017 Feb 14, 2018	BUY	$1.91 - $2.83 $1.58 Million - $2.34 Million	826,913	826,913 $1.74 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $333M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.